• Users Online: 446
  • Print this page
  • Email this page
This article has been cited by
1COVID-19 and phosphodiesterase enzyme type 5 inhibitors
HayderM Al-Kuraishy,AliI Al-Gareeb,MarwaS Al-Niemi,AliK Al-Buhadily,NasserA Al-Harchan,Claire Lugnier
Journal of Microscopy and Ultrastructure.2020;8(4)141
[DOI]
2Multidrug treatment for COVID-19
Masashi Ohe,Ken Furuya,Houman Goudarzi
Drug Discoveries & Therapeutics.2021;8(4)141
[DOI]
3COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin
Hayder M. Al-kuraishy,Ali I. Al-Gareeb,M. Alblihed,Natália Cruz-Martins,Gaber El-Saber Batiha
Frontiers in Medicine.2021;8(4)141
[DOI]
4Tetracycline plus macrolide: A potential therapeutic regimen for COVID-19?
Masashi Ohe,Ken Furuya,Houman Goudarzi
BioScience Trends.2020;14(6)467
[DOI]
5Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances
Hayder M. Al-kuraishy,Ali I. Al-Gareeb,Saleh M. Abdullah,Natália Cruz-Martins,Gaber El-Saber Batiha
Frontiers in Cardiovascular Medicine.2021;8(6)467
[DOI]